M&A Deal Summary

Sandoz International Acquires AmLactin

On December 19, 2016, Sandoz International acquired consumer products company AmLactin from Upsher-Smith Laboratories

Acquisition Highlights
  • This is Sandoz International’s 1st transaction in the Consumer Products sector.
  • This is Sandoz International’s 1st transaction in the United States.
  • This is Sandoz International’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2016-12-19
Target AmLactin
Sector Consumer Products
Buyer(s) Sandoz International
Sellers(s) Upsher-Smith Laboratories
Deal Type Divestiture

Target

AmLactin

Maple Grove, Minnesota, United States
AmLactin is a developer, manufacturer of skin care products including therapeutic moisturizers and conditioners. AmLactin is based in Maple Grove, Minnesota.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sandoz International

Holzkirchen, Germany

Category Company
Sector Life Science
DESCRIPTION

Sandoz International GmbH is a developer, manufacturer and markets generic pharmaceutical products focused on biosimilars, injectables, inhalers and transdermal patches.


DEAL STATS #
Overall 2 of 5
Sector: Consumer Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 4
State: Minnesota M&A 1 of 1
Country: United States M&A 1 of 2
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-08-16 Sabex Holdings

Boucherville, Quebec, Canada

Sabex Holdings Ltd. is a developer, manufacturer and distributor of generic small volume injectables, ophthalmics, suppositories, and other pharmaceutical products.

Buy $565M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-11 Aspen Global - Japanese Operations

Japan

Aspen Global, Inc.'s Japanese Operations is a provider of branded and generic pharmaceuticals.

Buy R6.5B

Seller(S) 1

SELLER

Upsher-Smith Laboratories

Maple Grove, Minnesota, United States

Category Company
Founded 1919
Sector Life Science
DESCRIPTION

Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota.


DEAL STATS #
Overall 1 of 2
Sector: Consumer Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 2
State: Minnesota M&A 1 of 2
Country: United States M&A 1 of 2
Year: 2016 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-20 Upsher-Smith Laboratories - Generics Business

Maple Grove, Minnesota, United States

Upsher-Smith Laboratories, Inc. - Generics Business is a manufacturer of generic products in Minnesota, United States.

Sell $1.1B